Our research in Leeds
Last year we spent over £3m on life-saving research in Leeds.
Leeds is home to one of our Clinical Trials Units (CTU), which deliver innovative and practice-changing clinical research that impacts the care and outcomes for cancer patients in the UK and across the world.
A Senior Research Nurse in Leeds supports the delivery of high-quality clinical trials and studies, getting new treatments into the clinic sooner.
Our Leeds Paediatric Experimental Cancer Medicine Centre (ECMC) is a partnership between CRUK and the National Institute for Health Research in England. It brings together lab scientists and cancer doctors to speed up the flow of ideas and new treatments from the lab to the clinic.
Establishing a UK-wide bowel cancer data hub
Could the bacteria in our gut help treat cancer?
Working out the shape of molecules to drive drug development
Professor Richard Bayliss is studying molecules involved in controlling how cells multiply.
What we're doing now
The Leeds Cancer Research UK CTU is one of only 7 clinical trials units to receive a prestigious infrastructure award from CRUK. Opened in 2018, the Leeds CRUK CTU aims to improve access to innovative treatments for cancer patients.
Professor Reuben Tooze is studying what happens when white blood cells in the bone marrow – called plasma cells – develop into myeloma.
Leeds scientists and clinicians have been awarded a major cash boost from CRUK to pioneer new radiotherapy technologies and techniques that could help more people survive cancer in the future.
Dr Martin Elliott leads the Leeds Paediatric Experimental Cancer Medicine Centre (ECMC), based at Leeds Children’s Hospital. The ECMCs bring together lab-based scientists and clinical researchers, enabling them to share ideas and resources to drive the discovery, development and testing of new anti-cancer treatments and tests for the benefit of patients.
News near Leeds
- 30,500 people are diagnosed with cancer each year.
- 50-59% of cancers are diagnosed early.
- Cancer deaths have fallen by 9% in the last 10 years.
Our strategy to beat cancer sooner
Our vision is to bring forward the day when all cancers are cured.Our new strategy will give us the foundations we need to tackle the challenges ahead.